NEW ORAL ANTICOAGULANTS
Posted in News
In January, the World Health Organisation made some changes to the defined daily doses (DDDs) of the new oral anticoagulant drugs (NOACs). In each case the DDD has been increased:
- Apixaban from 5mg to 10mg
- Dabigatran etexilate from 0.22g to 0.3g
- Rivaroxaban from 10mg to 20mg.
These increases in DDD will result in changes in DDD reports both historically and in the future, and also to the Usage Profile Cost Comparison report for ‘Anticoagulants – NOACs’.
An ATC code and a Defined Daily Dose are now available for edoxaban. The ATC code is B01AF03 and the defined daily dose is 60mg. The available products are included in the Define Tag ‘Anticoagulants – NOACs and warfarin’. Edoxaban products have not yet been included in the cost comparison report for new oral anticoagulants as the total NHS spend in England on edoxaban is currently a very small percentage of the total spend on NOACs.